Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Public Health ; 213: 28-33, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36332414

ABSTRACT

OBJECTIVES: This study aimed to examine the factors associated with low sugar-sweetened beverage (SSB) consumption and intention to avoid these products as well as investigate the role of different types of social norms in the adoption of this behaviour. STUDY DESIGN: This study reports the results of a secondary data analysis from a cross-sectional telephone survey. METHODS: A total of 1000 adults were randomly recruited in the province of Québec, Canada, using a random-digit dialling procedure. Eligibility criteria were to be aged between 18 and 64 years; able to answer a questionnaire in French or English; and to reside in the province of Québec. SSB consumption, social norms and variables from the theory of planned behaviour were assessed by means of a questionnaire. Logistic regression analyses were conducted to examine factors associated with behaviour and intention. RESULTS: Consuming <1 SSB per day was significantly associated with intention, perceived behavioural control, and risk perception about tooth decay. Descriptive (perceived prevalence in the close surroundings of one person) and perceived societal norms (perceived broad societal approval/disapproval of the behaviour) were associated with behaviour. All theory of planned behaviour variables (including injunctive norm) and risk perception pertaining to chronic diseases predicted intention to avoid the consumption of ≥1 SSB per day. Sex, age, income, and risk perception pertaining to chronic diseases were associated with perceived societal disapproval of SSB consumption. CONCLUSIONS: This study confirms the importance of social norms in the prediction of SSB consumption but also highlights the need to address motivation and capacities in public health interventions to reduce SSB consumption.


Subject(s)
Social Norms , Sugar-Sweetened Beverages , Humans , Adolescent , Young Adult , Adult , Middle Aged , Cross-Sectional Studies , Canada , Quebec
2.
Nutr Metab Cardiovasc Dis ; 29(7): 684-691, 2019 07.
Article in English | MEDLINE | ID: mdl-31078363

ABSTRACT

BACKGROUND AND AIMS: The "Life's Simple 7" (LS7) metrics were developed by the American Heart Association (AHA) to assess and promote cardiovascular health in the American population. The purpose of this study was to assess the overall cardiovascular health of French-speaking adults from the Province of Quebec using the LS7 score. METHODS AND RESULTS: A total of 777 age and sex-representative participants of five different administrative regions in the Province of Quebec (387 men and 390 women; mean age ± SEM: 41.9 ± 0.1 years) were included in these analyses. Metrics of the LS7 score (smoking, physical activity, diet, body mass index, blood pressure, fasting total cholesterol and blood glucose) were analysed to generate a final score ranging from 0 to 7. Only 0.5% of participants met all criteria for ideal cardiovascular health. The diet metric showed the lowest prevalence of "ideal" scores (4.8%) whereas not smoking was the metric with the highest prevalence (88.1%). Women had a higher LS7 score than men, while age and education level (negative and positive association, respectively; p < 0.0001) were also associated with the LS7 score. CONCLUSION: Consistent with studies conducted among other populations, very few French-speaking adults from the Province of Quebec achieve an ideal cardiovascular health. These data indicate that further public health efforts aimed at promoting the LS7 metrics, focusing primarily on diet, are urgently needed. Specific groups, including older adults and those with lower levels of education, should be targeted when developing cardiovascular health promotion interventions.


Subject(s)
American Heart Association , Cardiovascular Diseases/prevention & control , Health Status Indicators , Health Status , Healthy Lifestyle , Language , Primary Prevention , Risk Reduction Behavior , Adolescent , Adult , Aged , Biomarkers/blood , Blood Glucose/analysis , Blood Pressure , Body Mass Index , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Cholesterol/blood , Cross-Sectional Studies , Exercise , Female , Humans , Male , Middle Aged , Prevalence , Protective Factors , Quebec/epidemiology , Risk Assessment , Risk Factors , Smoking Cessation , United States , Young Adult
3.
J Hum Nutr Diet ; 27(4): 391-400, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24387074

ABSTRACT

BACKGROUND: Not all healthcare professionals are familiar with nutrigenomics. However, they recognise that nutrigenomics has great potential for the development of preventive health approaches. The present study aimed to provide an overall picture of the current situation about nutrigenomics in the practice of registered dietitians (RDs) from the province of Quebec (Canada). METHODS: Three hundred and seventy-three RDs members of the Ordre professionnel des diététistes du Québec completed an online survey that included 34 questions, most of which were closed-ended questions. RESULTS: Overall, 76.9% of RDs knew about nutrigenomics. Among RDs with <5 years of experience, 49.2% knew about genetic testing related to nutrition compared to 11.7% for RDs with over 25 years of experience. Currently, 75.9% of RDs working in clinical nutrition in the public sector consider that they do not have the basic knowledge to integrate nutrigenomics in their practice compared to 62.9% for RDs in private practice. When asked about main limitations of genetic testing related to nutrition, RDs considered that genetic testing does not consider the other determinants of health, that genetic testing and their results have poor accuracy, and that there is a lack of scientific evidence. Concerns remained about ethical and legal aspects and its difficult application as a result of poor understanding and/or interpretation by professionals and/or customers. The high costs of these tests were also noted as a limitation. CONCLUSIONS: Registered dietitians know and are interested in nutrigenomics, especially those with less experience, although they do not feel adequately qualified to integrate findings from nutrigenomics into their practice.


Subject(s)
Dietetics , Nutrigenomics/methods , Nutritionists , Referral and Consultation , Adult , Female , Genetic Testing , Health Knowledge, Attitudes, Practice , Humans , Male , Middle Aged , Nutritional Requirements , Quebec , Socioeconomic Factors , Surveys and Questionnaires
4.
Nutr Metab Cardiovasc Dis ; 21(9): 628-35, 2011 Sep.
Article in English | MEDLINE | ID: mdl-20554173

ABSTRACT

BACKGROUND AND AIMS: No study has yet examined how weight loss modifies the impact of the Mediterranean diet (MedDiet) on cardiovascular risk factors in men with the metabolic syndrome (MetS). The objective of the study was to assess the efficacy of MedDiet, with and without weight loss, to modify the cardiometabolic risk profile of male patients with MetS. METHODS AND RESULTS: Twenty-six men aged between 24 and 62 years with the MetS consumed a North American control diet for 5 weeks followed by a 5-week MedDiet, both under weight-maintaining conditions. Participants then underwent a 20-week weight loss period, after which they consumed the MedDiet for five weeks under weight stable conditions. Body weight was reduced by 10.2% ± 2.9% after the weight loss period (p < 0.001). All foods were provided to participants during the weight stable phases of the study. The MedDiet in the absence of weight loss decreased total plasma cholesterol (C) (-7.1%), LDL-C (-9.3%) and the total/HDL-C ratio (-6.5%) compared to the control diet (all p < 0.04). The MedDiet combined with weight loss led to reductions in systolic blood pressure (-4.7%), diastolic blood pressure (-7.7%), triglycerides (-18.2%), ApoB (-10.7%), fasting glucose (-4.2%) and insulin (-29.9%) compared to the control diet (all p < 0.001). CONCLUSION: The MedDiet in the absence of weight loss leads to significant changes in plasma cholesterol concentrations but has little effects on other cardiometabolic risk factors associated with the MetS in men.


Subject(s)
Cardiovascular Diseases/prevention & control , Diet, Mediterranean , Weight Loss/drug effects , Adult , Anthropometry , Apolipoproteins B/blood , Blood Glucose/analysis , Blood Pressure/drug effects , Caloric Restriction , Cardiovascular Diseases/etiology , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Humans , Male , Metabolic Syndrome/complications , Middle Aged , Patient Compliance , Risk Assessment , Risk Factors , Triglycerides , Young Adult
5.
Eur J Clin Nutr ; 62(1): 10-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17299465

ABSTRACT

OBJECTIVE: To compare the effect of a high monounsaturated fatty acid (MUFA) diet and of a control low-fat diet consumed under ad libitum conditions on plasma apolipoprotein (apo) C-III metabolism. DESIGN: Randomized, two-arm parallel dietary trial. SETTING: Diets were prepared and consumed at the metabolic kitchen of the Department of Food Sciences and Nutrition, and laboratory analyses were performed at the Institute of Nutraceuticals and Functional Foods at Laval University. SUBJECTS AND INTERVENTIONS: Eighteen men were randomly assigned to either the high MUFA diet or the low-fat control diet, which they consumed for 6-7 weeks. Before and after the dietary intervention, subjects received a primed-constant infusion of [5,5,5-D(3)]-L-leucine for 12 h under constant feeding conditions for the determination of plasma apoC-III kinetics. RESULTS: The high-MUFA diet and the low-fat control diet had no significant impact on plasma apoC-III production rate (PR) or fractional catabolic rate. However, diet-induced variations in plasma apoCIII PR predicted the reduction in plasma triglycerides and apoC-III levels (r=0.85, P<0.01 and r=0.73, P<0.05, respectively) in the high MUFA group only. CONCLUSIONS: These results suggest that the hypotriglyceridemic effect of a high-MUFA diet may be attributable in part to a reduced hepatic production of apoC-III. SPONSORSHIP: This study was supported in part by an operating grant from the Canadian Institutes of Health Research (CIHR), and the Canada Research Chair in Nutrition and Cardiovascular Health (B Lamarche).


Subject(s)
Apolipoprotein C-III/metabolism , Diet, Fat-Restricted , Fatty Acids, Monounsaturated/pharmacology , Liver/metabolism , Triglycerides/blood , Adult , Apolipoprotein C-III/blood , Deuterium , Fatty Acids, Monounsaturated/administration & dosage , Humans , Leucine/pharmacokinetics , Liver/drug effects , Male
6.
J Inorg Biochem ; 81(4): 301-12, 2000 Oct 01.
Article in English | MEDLINE | ID: mdl-11065194

ABSTRACT

Recent epidemiological studies have confirmed the existence of a correlation between aluminum level in low-silica drinking water and prevalence of Alzheimer's disease. Also, oral aluminum-based phosphate binders and antacids may induce acute aluminum toxicity. Whatever the source of the metal ingested, its bioavailability is a function of the chemical forms under which it occurs in the gastrointestinal tract, i.e. of the ligands with which the Al3+ ion may associate. Dietary acids in particular can favor the bioavailability of aluminum in different ways: by increasing its solubility, by complexing it into neutral species, and/or by acting indirectly on its absorption process. Among these, tartaric acid is commonly found in fruits and in industrial foods and drinks, and may therefore be ingested together with environmental or/and therapeutic aluminum. The present work examines its potential influence on aluminum bioavailability. Firstly, Al(III)-tartrate complex formation constants have been determined under physiological conditions (37 degrees C, 0.15 M NaCl). Then these constants have been used to simulate the influence of tartrate on aluminum speciation in different gastrointestinal situations in which phosphate was also taken into account. Under normal conditions of aluminum contamination, tartrate is expected to keep the metal soluble throughout the whole pH range of the small intestine, which is likely to enhance its bioavailability. Even at low concentrations, tartrate also gives rise to two neutral complexes that span over the 1.5-7.5 pH interval, a phenomenon that is aggravated by increased aluminum levels as may result from aluminum hydroxide therapy. The co-occurrence of dietary phosphate reduces the fraction of aluminum neutralized by tartrate under normal conditions, but this effect quickly decreases with increasing aluminum doses. Even the therapeutic use of aluminum phosphate is not expected to be totally safe in the presence of tartaric acid. As plasma simulations show that no aluminum mobilization can be expected from tartrate that could enhance aluminum excretion, avoiding ingestion of tartaric acid during any form of aluminum-based therapy appears advisable.


Subject(s)
Aluminum/chemistry , Aluminum/pharmacokinetics , Tartrates/chemistry , Tartrates/pharmacokinetics , Aluminum/metabolism , Biological Availability , Blood/metabolism , Body Fluids/metabolism , Computer Simulation , Digestive System/metabolism , Humans , Tartrates/metabolism
7.
J Inorg Biochem ; 75(1): 27-35, 1999 May 30.
Article in English | MEDLINE | ID: mdl-10402674

ABSTRACT

While the involvement of environmental aluminum toxicity in the advent of senile dementias is still debated, acute aluminum toxicity of iatrogenic origin is well documented. So far, the only treatment available against it has been desferrioxamine (DFO), which induces major side effects. New drugs are thus highly desirable, and possible DFO substitutes have already been considered through various techniques. An important test for such new drugs is to assess their A1-mobilizing capacity in vivo. This can be done by computer-aided speciation provided formation constants for the corresponding A1(III) complexes are known beforehand. The present work reports an investigation of A1(III) complex equilibria with five sequestering ligands including DFO, and predicts the respective capacities of these to mobilize aluminum in vivo under normal and inflammatory conditions.


Subject(s)
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt/metabolism , Aluminum/metabolism , Body Fluids/metabolism , Chelating Agents/metabolism , Computer Simulation , Iron Chelating Agents/metabolism , Animals , Chelating Agents/adverse effects , Deferiprone , Deferoxamine/adverse effects , Deferoxamine/metabolism , Humans , Hydroxybenzoates/metabolism , Indicators and Reagents , Inflammation/metabolism , Ligands , Pyridones/metabolism , Rabbits , Rats , Reproducibility of Results
8.
Life Sci ; 47(15): 1299-307, 1990.
Article in English | MEDLINE | ID: mdl-2233133

ABSTRACT

Bile acids are major determinants of canalicular bile secretion, and there are indications that choleretic bile acids increase bile canalicular contractions, in isolated rat hepatocytes. Therefore, we examined the influence of various bile acids on the rate of actin polymerization in vitro. The free forms of cholic acid, ursodeoxycholic acid, and chenodeoxycholic acid, as well as their taurine and glycine conjugates, were incubated with purified muscle actin, at a concentration of 100-300 nmoles/mg actin. The rate of actin polymerization was measured by viscometry and the fluorescence of the pyrene probe, linked to actin. Results showed that all bile acids slow the rate of polymerization, and that the effect was dose-dependent. However, the reduction by chenodeoxycholic acid was greater than that caused by the other bile acids. The results indicate that bile acids, particularly in high concentrations interact with actin, a finding that may be related to the increased bile canalicular contractility, and altered canalicular membrane morphology, induced by choleretic bile acids.


Subject(s)
Actins/chemistry , Bile Acids and Salts/pharmacology , Actins/ultrastructure , Animals , Bile Canaliculi/ultrastructure , Chenodeoxycholic Acid/pharmacology , Cholic Acid , Cholic Acids/pharmacology , Kinetics , Magnesium Chloride/pharmacology , Microscopy, Electron , Polymers/chemistry , Rabbits , Rats , Spectrometry, Fluorescence , Ursodeoxycholic Acid/pharmacology , Viscosity
SELECTION OF CITATIONS
SEARCH DETAIL
...